ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $806 | -11.7% | 29,730 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $913 | -14.7% | 29,730 | +0.1% | 0.00% | 0.0% |
| Q1 2023 | $1,070 | -16.4% | 29,702 | -8.4% | 0.00% | -50.0% |
| Q4 2022 | $1,280 | -99.9% | 32,411 | +0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,301,000 | -4.5% | 32,401 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,362,000 | +27.2% | 32,401 | +51.4% | 0.00% | +100.0% |
| Q4 2020 | $1,071,000 | – | 21,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |